CRVO 25 year old man - Factor V Leiden Heterozygous
|
|
25 year old man with 1 week vision loss 20/16 OD 20/100 OS - CRVO
Heterozyrous for Factor V Leiden - Required 3 years of Lucentis - VA improved to 20/30. Able to stop therapy
|
CRVO 25 year old man - Heterozygous Factor V Leidenvaatamisi: 45120/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.
(0 hinnangut)
|
|
CRVO 25 year old man - Heterozygous Factor V Leidenvaatamisi: 36020/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.
(0 hinnangut)
|
|
CRVO 25 year old man - Heterozygous Factor V Leidenvaatamisi: 41920/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.
(0 hinnangut)
|
|
CRVO 25 year old man - Heterozygous Factor V Leidenvaatamisi: 36120/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.
(0 hinnangut)
|
|
CRVO 25 year old man - Heterozygous Factor V Leidenvaatamisi: 39320/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.
(0 hinnangut)
|
|
CRVO 25 year old man - Heterozygous Factor V Leidenvaatamisi: 37020/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.
(0 hinnangut)
|
|
CRVO 25 year old man - Heterozygous Factor V Leidenvaatamisi: 43220/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.
(0 hinnangut)
|
|
CRVO 25 year old man - Heterozygous Factor V Leidenvaatamisi: 37320/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.
(0 hinnangut)
|
|
CRVO 25 year old man - Heterozygous Factor V Leidenvaatamisi: 38120/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.
(0 hinnangut)
|
|
CRVO 25 year old man - Heterozygous Factor V Leidenvaatamisi: 36220/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.
(0 hinnangut)
|
|
CRVO 25 year old man - Heterozygous Factor V Leidenvaatamisi: 36620/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.
(0 hinnangut)
|
|
CRVO 25 year old man - Heterozygous Factor V Leidenvaatamisi: 36920/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.
(0 hinnangut)
|
|
CRVO 25 year old man - Heterozygous Factor V Leidenvaatamisi: 37920/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.
(0 hinnangut)
|
|
CRVO 25 year old man - Heterozygous Factor V Leidenvaatamisi: 35720/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.
(0 hinnangut)
|
|
CRVO 25 year old man - Heterozygous Factor V Leidenvaatamisi: 37920/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.
(0 hinnangut)
|
|
CRVO 25 year old man - Heterozygous Factor V Leidenvaatamisi: 36820/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.
(0 hinnangut)
|
|
CRVO 25 year old man - Heterozygous Factor V Leidenvaatamisi: 34720/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.
(0 hinnangut)
|
|
CRVO 25 year old man - Heterozygous Factor V Leidenvaatamisi: 38620/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.
(0 hinnangut)
|
|
CRVO 25 year old man - Heterozygous Factor V Leidenvaatamisi: 36720/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.
(0 hinnangut)
|
|
CRVO 25 year old man - Heterozygous Factor V Leidenvaatamisi: 32420/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.
(0 hinnangut)
|
|
CRVO 25 year old man - Heterozygous Factor V Leidenvaatamisi: 34220/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.
(0 hinnangut)
|
|
CRVO 25 year old man - Heterozygous Factor V Leidenvaatamisi: 37920/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.
(0 hinnangut)
|
|
CRVO 25 year old man - Heterozygous Factor V Leidenvaatamisi: 37220/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.
(0 hinnangut)
|
|
CRVO 25 year old man - Heterozygous Factor V Leidenvaatamisi: 40320/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.
(0 hinnangut)
|
|
CRVO 25 year old man - Heterozygous Factor V Leidenvaatamisi: 35120/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.
(0 hinnangut)
|
|
|
|
|
|
|
25 year old man with 1 week vision loss 20/16 OD 20/100 OS - CRVO
Heterozyrous for Factor V Leiden - Required 3 years of Lucentis - VA improved to 20/30. Able to stop therapy
